DELRAY BEACH, Fla., June 13, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID") (Nasdaq:PSID), a leader in next generation patient monitoring and diagnostics, announced today that it has partnered with Rogers Communications, Canada's largest wireless provider, to improve diabetes management through the companies' innovative mobile technology. Through this strategic relationship, Rogers Communications will provide PositiveID with machine-to-machine (M2M) wireless data and mobile connectivity management services to enable the communication of a diabetes patient's glucose readings from PositiveID's iglucose™ solution.
"We are excited to partner with Rogers and utilize its robust network and innovative device management platform to enhance our iglucose system," said Scott R. Silverman, Chairman and CEO of PositiveID regarding the partnership with Rogers Communications. "This positions the companies to provide a complete, consistent solution for people living with diabetes. As we launch the innovative iglucose service, we will have a technology platform in place capable of handling our business as it grows throughout Canada."
PositiveID's iglucose system ( www.iglucose.com ) is an innovative mobile health solution designed to facilitate diabetes management by automatically creating logs and journals, which the American Diabetes Association says are an important assessment of an individual's response to their diabetes care plan. iglucose provides next generation data to facilitate diabetes management by helping ensure patient compliance and data accuracy, and aiding in insurance reimbursement.
According to the Canadian Diabetes Association, more than 9 million Canadians live with diabetes or prediabetes. Worldwide, an estimated 285 million people worldwide are affected by diabetes. With an additional 7 million people developing diabetes each year, this number is expected to hit 438 million by 2030.
About PositiveID Corporation
PositiveID Corporation develops unique medical devices and biological detection systems, focused primarily on diabetes management, rapid medical testing and airborne bio-threat detection. Its wholly-owned subsidiary, MFSI, is focused on the development of microfluidic systems for automated preparation of and performance of biological assays. For more information on PositiveID, please visit .
The PositiveID Corporation logo is available at
Statements about PositiveID's future expectations, including its abilityto improve diabetes management through its innovative mobile technology; the likelihood that partnering with Rogers and utilizing its robust network and innovative device management platform will enhance PositiveID's iglucose system and position the companies to provide a complete, consistent solution for people living with diabetes; the likelihood that as PositiveID launches the iglucose service, it will have a technology platform in place capable of handling its business as it grows throughout Canada; the ability of iglucose to provide next generation data to facilitate diabetes management by helping ensure patient compliance and data accuracy, and aiding in insurance reimbursement; and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID's actual results could differ materially from expected results. These risks and uncertainties include the Company's ability to successfully commercialize the iglucose system in Canada, as well as certain other risks. Additional information about these and other factors that could affect the Company's business is set forth in the Company's various filings with the Securities and Exchange Commission, including those set forth in the Company's 10-K filed on March 25, 2011, and Form 10-Q filed on May 13, 2011, under the caption "Risk Factors." The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.
CONTACT: Allison Tomek 561-805-8000 firstname.lastname@example.org Dan Schustack CEOcast 212-732-4300 email@example.com